HRP20050173A2 - Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition - Google Patents
Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comositionInfo
- Publication number
- HRP20050173A2 HRP20050173A2 HR20050173A HRP20050173A HRP20050173A2 HR P20050173 A2 HRP20050173 A2 HR P20050173A2 HR 20050173 A HR20050173 A HR 20050173A HR P20050173 A HRP20050173 A HR P20050173A HR P20050173 A2 HRP20050173 A2 HR P20050173A2
- Authority
- HR
- Croatia
- Prior art keywords
- composition containing
- androgenous
- halogensteroid
- comosition
- male contraceptive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10234525A DE10234525A1 (de) | 2002-07-25 | 2002-07-25 | Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung |
| US44940003P | 2003-02-25 | 2003-02-25 | |
| PCT/EP2003/008192 WO2004011008A1 (fr) | 2002-07-25 | 2003-07-25 | COMPOSITION CONTENANT UN 11β-HALOGENOSTEROIDE ANDROGENE ET UN GESTAGENE, ET CONTRACEPTIF MASCULIN A BASE DE CETTE COMPOSITION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050173A2 true HRP20050173A2 (en) | 2005-04-30 |
Family
ID=31189299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050173A HRP20050173A2 (en) | 2002-07-25 | 2005-02-22 | Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20060100180A1 (fr) |
| EP (1) | EP1524983B1 (fr) |
| JP (1) | JP2006502997A (fr) |
| KR (1) | KR20050025985A (fr) |
| CN (1) | CN1671394A (fr) |
| AT (1) | ATE382355T1 (fr) |
| AU (1) | AU2003251636B2 (fr) |
| BR (1) | BR0312922A (fr) |
| CA (1) | CA2493207A1 (fr) |
| DE (1) | DE50308933D1 (fr) |
| EC (1) | ECSP055629A (fr) |
| ES (1) | ES2299735T3 (fr) |
| HR (1) | HRP20050173A2 (fr) |
| IL (1) | IL166432A0 (fr) |
| MX (1) | MXPA05001017A (fr) |
| PL (1) | PL374317A1 (fr) |
| WO (1) | WO2004011008A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101041328B1 (ko) * | 2002-07-24 | 2011-06-14 | 바이엘 쉐링 파마 악티엔게젤샤프트 | ７ 알파-치환 １１ 알파-히드록시 스테로이드의 생산을위한 미생물학적 방법 |
| DE10233723A1 (de) | 2002-07-24 | 2004-02-12 | Schering Ag | Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene |
| WO2013078422A2 (fr) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Préparations et thérapies de substitution pour hormonothérapie naturelle combinée |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2015179782A1 (fr) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Formulations d'hormones substitutives combinées naturelles et traitement hormonal substitutif |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173071A1 (fr) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Composition pharmaceutique d'hormone stéroïde |
| WO2017173044A1 (fr) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3714965A1 (de) * | 1987-04-30 | 1988-11-10 | Schering Ag | 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE19650352A1 (de) * | 1996-12-04 | 1998-07-30 | Jenapharm Gmbh | Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann |
| US5952319A (en) * | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
| DE19848303A1 (de) * | 1998-10-14 | 2000-04-20 | Schering Ag | Kombination aus Gestagenen und Zuckern |
| DE60127103T2 (de) * | 2000-02-15 | 2007-11-22 | Bayer Schering Pharma Ag | Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend |
| EP1216699A1 (fr) * | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Système transdermique comprenant un progestatif très puissant |
| DE10104327A1 (de) * | 2001-01-24 | 2002-07-25 | Schering Ag | 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate |
-
2003
- 2003-07-25 PL PL03374317A patent/PL374317A1/xx not_active Application Discontinuation
- 2003-07-25 MX MXPA05001017A patent/MXPA05001017A/es active IP Right Grant
- 2003-07-25 JP JP2004523798A patent/JP2006502997A/ja active Pending
- 2003-07-25 US US10/522,169 patent/US20060100180A1/en not_active Abandoned
- 2003-07-25 DE DE50308933T patent/DE50308933D1/de not_active Expired - Fee Related
- 2003-07-25 EP EP03771100A patent/EP1524983B1/fr not_active Expired - Lifetime
- 2003-07-25 CA CA002493207A patent/CA2493207A1/fr not_active Abandoned
- 2003-07-25 AT AT03771100T patent/ATE382355T1/de not_active IP Right Cessation
- 2003-07-25 ES ES03771100T patent/ES2299735T3/es not_active Expired - Lifetime
- 2003-07-25 BR BR0312922-5A patent/BR0312922A/pt not_active IP Right Cessation
- 2003-07-25 WO PCT/EP2003/008192 patent/WO2004011008A1/fr active IP Right Grant
- 2003-07-25 CN CNA038177900A patent/CN1671394A/zh active Pending
- 2003-07-25 AU AU2003251636A patent/AU2003251636B2/en not_active Ceased
- 2003-07-25 KR KR1020057001264A patent/KR20050025985A/ko not_active Application Discontinuation
-
2005
- 2005-01-20 IL IL16643205A patent/IL166432A0/xx unknown
- 2005-02-22 HR HR20050173A patent/HRP20050173A2/xx not_active Application Discontinuation
- 2005-02-24 EC EC2005005629A patent/ECSP055629A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE50308933D1 (de) | 2008-02-14 |
| ATE382355T1 (de) | 2008-01-15 |
| CA2493207A1 (fr) | 2004-02-05 |
| AU2003251636B2 (en) | 2009-10-22 |
| PL374317A1 (en) | 2005-10-03 |
| JP2006502997A (ja) | 2006-01-26 |
| EP1524983B1 (fr) | 2008-01-02 |
| MXPA05001017A (es) | 2005-06-08 |
| EP1524983A1 (fr) | 2005-04-27 |
| AU2003251636A1 (en) | 2004-02-16 |
| CN1671394A (zh) | 2005-09-21 |
| WO2004011008A1 (fr) | 2004-02-05 |
| ES2299735T3 (es) | 2008-06-01 |
| ECSP055629A (es) | 2005-04-18 |
| US20060100180A1 (en) | 2006-05-11 |
| KR20050025985A (ko) | 2005-03-14 |
| BR0312922A (pt) | 2005-07-12 |
| IL166432A0 (en) | 2006-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050173A2 (en) | Composition containing an androgenous 11?-halogensteroid and a progestational hormone, and male contraceptive based on said comosition | |
| HK1084941A1 (en) | Compounds and their use | |
| MD1233B1 (en) | Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof | |
| EP1632237A3 (fr) | Compositions comprenant de la drospirenone et un complexe entre l'ethinyl-oestradiol et une cyclodextrine | |
| HK1078588A1 (en) | Process to prepare eplerenone | |
| MY129450A (en) | Pharmaceutical composition | |
| EP1105407A4 (fr) | Composes aminosteroliques et utilisations correspondantes | |
| AU2002317298A1 (en) | Formulation comprising fulvestrant | |
| AU2003255355A1 (en) | Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy | |
| HK1060558A1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof. | |
| GB0202635D0 (en) | Formulation containing novel anti-inflammatory androstane derivative | |
| AU2003267551A1 (en) | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone | |
| RS20050049A (en) | Composition containing an andogenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition | |
| NZ515685A (en) | Use of riluzole for the treatment of multiple sclerosis | |
| IL109866A (en) | Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it | |
| EP0717618A4 (fr) | Formulation stabilisee pour comprimes | |
| PL1635843T3 (pl) | Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest | |
| WO2003035043A3 (fr) | Formulation | |
| DE60212130D1 (en) | Carvedilolpolymorph | |
| WO1996028154A3 (fr) | Utilisation d'anti-oestrogenes comme contraceptifs masculins | |
| AU2002240936A1 (en) | Use of erss-selective ligands for regulating fertility and compounds useful therefore | |
| 姚晶晶 et al. | My Happiest Day |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| PNAN | Change of the applicant name, address/residence |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE |
|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090722 Year of fee payment: 7 |
|
| OBST | Application withdrawn |